Finance

Lists
Why is GYRE up 15.59%?
Dive Deeper
GYRE:NASDAQ
Gyre Therapeutics Inc
US$4.64
+15.59%
(+0.62) 1D
ኖቬም 6, 2:18:07 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
US$4.56
High
US$4.72
Low
US$4.08
Mkt. cap
491.47 ሚ
Avg. vol.
159.81 ሺ
Volume
264.38 ሺ
52-wk high
US$9.14
52-wk low
US$4.00
EPS
-US$0.20
Beta
2.43
Shares outstanding
106.03 ሚ
No. of employees
625
Open
US$4.56
High
US$4.72
Low
US$4.08
Mkt. cap
491.47 ሚ
Avg. vol.
159.81 ሺ
Volume
264.38 ሺ
52-wk high
US$9.14
52-wk low
US$4.00
EPS
-US$0.20
Beta
2.43
Shares outstanding
106.03 ሚ
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
Headquartersዊንስተን-ሳሌም, ኖርዝ ካሮላይና, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current US$4.64
US$20.00 (+331.50%)
Average
US$19.00 (+309.92%)
Lowest
US$18.00 (+288.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
US$18.00
+288.3%
11/06/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
US$20.00
+331.5%
08/10/2026
Roger Song
Jefferies
Buy
Initiated
US$16.00
+245.2%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
30.56 ሚ
37.20 ሚ
24.43 ሚ
29.10 ሚ
Cost of goods sold
1.63 ሚ
1.74 ሚ
1.23 ሚ
2.21 ሚ
Cost of revenue
1.63 ሚ
1.74 ሚ
1.23 ሚ
2.21 ሚ
Research and development expenses
2.36 ሚ
4.82 ሚ
11.48 ሚ
19.14 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.65 ሚ
30.52 ሚ
24.31 ሚ
21.62 ሚ
Operating expense
22.01 ሚ
35.33 ሚ
35.79 ሚ
40.76 ሚ
Total operating expenses
23.64 ሚ
37.08 ሚ
37.02 ሚ
42.97 ሚ
Operating income
6.93 ሚ
120.00 ሺ
-12.59 ሚ
-13.86 ሚ
Other non operating income
604.00 ሺ
-2.31 ሚ
244.00 ሺ
-811.00 ሺ
EBT including unusual items
7.63 ሚ
-66.00 ሺ
-18.03 ሚ
-14.43 ሚ
EBT excluding unusual items
7.63 ሚ
-864.00 ሺ
-11.65 ሚ
-13.93 ሚ
Income tax expense
1.69 ሚ
1.30 ሚ
549.00 ሺ
-164.00 ሺ
Effective tax rate
22.19%
-1,969.70%
-3.04%
1.14%
Other operating expenses
-
-
-
-
Net income
3.61 ሚ
-1.72 ሚ
-10.30 ሚ
-10.60 ሚ
Net profit margin
11.81%
-4.63%
-42.16%
-36.44%
Earnings per share
0.03
0.05
-
-
Interest and investment income
100.00 ሺ
1.35 ሚ
743.00 ሺ
740.00 ሺ
Interest expense
-
-
-
-
Net interest expenses
100.00 ሺ
1.35 ሚ
743.00 ሺ
740.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
7.58 ሚ
815.00 ሺ
-11.92 ሚ
-12.38 ሚ
Gain or loss from assets sale
1.00 ሺ
2.00 ሺ
16.00 ሺ
2.00 ሺ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች